Merck & co. , inc. MRK.US Overview Analysis
)MRK AI Analysis Overview
Keys for Bullish View
- Value≥4
- Dividend≥2
Value: 3
With average fundamentals, the stock maintains stable profits, indicating reliability.
Dividend: 5
With the stock maintains stable profits, the stock maintains stable profits, indicating reliability.
Whale Interest: 4
BonusInstitutions are positioning with focused holdings, hinting at stable long-term growth.
Analysis Conclusion
The stock holds a moderate value rating. If you have positions, consider retaining; for new ones, wait for a value score above 4.
MRK Current Performance
-0.10%
Merck & co. , inc.
3.56%
Avg of Sector
1.47%
S&P500
Top 10 High Relevance to MRK
- AZN Astrazeneca plcValue 4Trend 3Swing Trading 5Whale Interest 2Dividend 5See more
MRK Profile
Merck & Co., Inc. is a global health care company that delivers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. The Company's segments include Pharmaceutical and Animal Health. Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. It sells its human health vaccines primarily to physicians, wholesalers, distributors and government entities. Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all major livestock and companion animal species. It sells its products to veterinarians, distributors, animal producers, farmers and pet owners.